This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Plan zero based budgets for families to create a shared financial vision, allocate funds, and pursue common goals together.
19,937 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Bitcoin slips below the $70,000 mark as oil prices surge and geopolitics roil markets. Analysts warn the crypto may c...
BitFuFu reports 2025 results showing a shift toward cloud mining and a swing into loss as energy costs rise and Bitco...
The Fed has stopped cutting rates, but that doesn’t mean investors should abandon Realty Income. This article explain...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...
Three ETFs have stood out in 2026 by delivering positive returns while the S&P 500 retreats. RSP, NLR, and VXUS are t...
NVIDIA still leads the AI chip race, but investors are spreading bets downstream to adjacent AI opportunities as the ...
A four-year tax window under SECURE 2.0 lets workers aged 60-63 contribute up to $11,250 a year to a 401(K). Surgeons...
When a seasoned media veteran weighs in on CNN, it’s more than a rumor. This article translates that talk into action...
Investors are watching Criteo's early 2026 results to gauge the ad-tech pioneer's progress in privacy-friendly target...
The AI boom is reshaping the chip landscape. This guide identifies the best chips stocks right now and shows investor...
SVB Capital, the bank's roughly $10 billion venture arm, is being shopped as regulators unwind SVB assets. Buyers are...